Blog
HCFS employees highly respected industry known Subject Matter Experts are sought after to speak regularly for not only our clients, but a myriad of industry organizations. Our team is dedicated to not only FWA detection and prevention, but to education. We provide complimentary scheme oriented articles used by both clients and non-clients providing actionable takeaways and insights that have led to millions of dollars of savings and recoveries. Sign up for our newsletter!
Small Patients, Big Challenges: Using Modifier 63
This article delves into modifier 63, a key piece for dealing with the smallest patients, infants weighing less than 4 kg. Modifier 63 addresses the additional time, complexities, and challenges of...
Nuedexta: Laughter, Tears, & Off-Label Use
Nuedexta, a drug marketed for Pseudobulbar Affect (PBA), a condition causing uncontrollable laughing or crying, finds itself under a cloud of controversy. According to the manufacturer[1]: “PBA is a...
Off-Label Use Of Adderall
In this article, we discuss Adderall and its treatment for Attention-Deficit/Hyperactivity Disorder (ADHD) as well concerns expressed by Federal agencies regarding Adderall drug shortages...
Time is Money: Automating Your Case Prioritization Process
Who has enough time in their day to do everything you need to do? Almost no one. If you are going to the NHCAA Annual Training Conference in Dallas, then you don't want to miss this session. If you...
Transfixed by the SI Joint
There has been a seismic change to the coding and reimbursement for sacroiliac (SI) joint procedures over the last few years – we’re “transfixed” on this hot topic. New and disruptive minimally...
Learning About Lancets
For those afflicted with diabetes, managing all the different devices and the disease may feel like a daunting task. Even more intimidating may be learning what devices are covered and how much is...